For the first quarter of 2022, booster vaccine allowance would focus on AstraZeneca vaccine considering its adequate supply
Jakarta – The Indonesian Federal government would focus on the use of AstraZeneca vaccine as booster dosage in the first quarter of 2022, an authorities of the Health Ministry said.
” For the first quarter of 2022, booster vaccine allocation will focus on AstraZeneca vaccine considering its adequate supply,” the ministry’s spokesperson for COVID-19 vaccination, Siti Nadia Tarmidzi, said here on Sunday.
AstraZeneca vaccine can be administered with an interval of 8 weeks after the full-dose primary vaccination.
The booster vaccination might be conducted at the same time in all districts/cities regardless the accomplishment of 70 percent vaccination target and 60 percent of first dose vaccination for the elderly.
Those who will get the booster vaccine are needed to show their identity card numbers or PeduliLindungi application, 18 years of ages or above, currently have full-dose primary vaccination a minimum of six months before the booster vaccination.
Related news: Daily COVID-19 cases reach 11,588, Jakarta clocks highest cases
Individuals who got Sinovac as primary vaccine would get half dosage of AstraZeneca (0.15 ml) as booster vaccine while those who received AstraZeneca as main vaccine would get half dosage of Moderna (0.15 ml), or full dosage of AstraZeneca (0.5 ml) as booster vaccine.
” These (vaccine mixed drink) has actually been studied by health experts such as the Indonesian Technical Advisory Group on Immunization (ITAGI), the Drug and Food Monitoring Company (BPOM) in addition to academics,” she stated.
A research study found that a third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech, or Johnson & Johnson increases antibody levels significantly in those who have actually previously gotten 2 doses of Sinovac shot.
Associated news: W Jakarta pushes booster vaccinations to protect individuals from Omicron
